Intravenous news: The Association for Vascular Access (AVA) has a new president and president-elect, along with two new board members. The new officers and board
- President: Paul Blackburn, BSN, MNA, RN, VA-BC, Senior Director of Marketing and Education for RyMed Technologies, Inc., which manufactures needleless access devices for catheter care management.
- President-elect: Jim Lacy, BSN, RN, CRNI, VA-BC, Senior Clinical Marketing Specialist, Vascular Division of Teleflex Incorporated, a manufacturer of vascular access and medical devices.
- Board member: Jennifer McCord, MSN, RN, PCCN, CCRN, CCNS, VA-BC, Clinical Nurse Specialist, Critical Care and Vascular Access at Bethesda North Hospital, part of the TriHealth hospital system in Cincinnati, Ohio. McCord founded the vascular access team at the hospital.
- Board member: Michael Brazunas, BSN, RN, VA-BC, a Clinical Specialist for AngioDynamics, a manufacturer of medical products including vascular access products.
“The introduction of new board members influences AVA’s direction every year because of the new members’ unique perspectives and experiences,” said P.J. Haylock, Ph.D., RN, FAAN, and AVA’s CEO. “It is also exciting to welcome a new president. Paul Blackburn is passionate about moving AVA to the next level and in doing so, advancing patient safety and the art and science of vascular access.”
Blackburn outlined several objectives he has set for his presidency:
- Expanding the AVA membership “to embrace the diversity that exists within the science of vascular access.”
- Fostering research to support evidence-based standards for vascular access practice.
- Strengthening AVA’s position as the voice of vascular access through continued collaboration in public policy and healthcare legislation.
- Working with the Vascular Access Certification Corporation to provide the support necessary for additional levels of certification.
- Finding ways to ensure that more AVA Network members are motivated to join the national organization.
“I believe strongly in AVA and its ability to chart the future of vascular access,” said Blackburn. “The goals I have set for the organization are the outline of a strategic plan that can accomplish that objective.”
Blackburn’s term as president brings to a close the presidency of Jack LeDonne, M.D., VA-BC. LeDonne will continue to serve as Presidential Advisor. President-elect Lacy fills the vacancy left by Blackburn as he assumes the presidency. New board members McCord and Brazunas, who are Directors-at-Large, replace departing board members Tim Royer, BSN, CRNI, and Thomas Vesely, M.D.
Additional board members are Rich Lewis, BS, RN (Treasurer); Deborah Phelan, RN (Secretary); and Directors-at-Large Mark Rowe, MNSc, RNP, VA-BC; Linda Lembo, MSN/Ed, CRNI, VA-BC; and Michele Biscossi, MS, ACNP-BC, RN, CNL.